Sanofi (SNY) Short-term Investments (2009 - 2021)

Sanofi has disclosed Short-term Investments across 13 years of filings, most recently posting $12.5 million for Q4 2021.

• Short-term Investments for Q4 2021 came in at $12.5 million, down 93.18% year-over-year; the trailing twelve-month figure through Dec 2021 was $12.5 million (down 93.18% YoY), and the FY2021 annual result was $12.9 million, down 92.64% from the prior year.
• Short-term Investments came in at $12.5 million for Q4 2021 at Sanofi, down from $182.9 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $227.1 million in Q4 2018 to a low of $12.5 million in Q4 2021.
• The 5-year median for Short-term Investments is $147.0 million (2019), against an average of $132.0 million.
• Across the five-year window, Short-term Investments surged 170.86% in 2017 and slumped 93.18% in 2021, its largest moves.
• Sanofi's Short-term Investments stood at $90.7 million in 2017, then jumped by 150.53% to $227.1 million in 2018, then plunged by 35.28% to $147.0 million in 2019, then climbed by 24.42% to $182.9 million in 2020, then slumped by 93.18% to $12.5 million in 2021.
• The last three Short-term Investments figures came in at $12.5 million (Q4 2021), $182.9 million (Q4 2020), and $147.0 million (Q4 2019), per Business Quant data.